Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Medacta Group SA
  6. Summary
    MOVE   CH0468525222

MEDACTA GROUP SA

(MOVE)
  Report
Delayed Swiss Exchange  -  11:30 2022-12-05 am EST
101.00 CHF   +0.60%
11/15Global markets live: Amazon, Berkshire Hathaway, Infineon, Home Deport Walmart...
MS
11/15Medacta Settles Patent Disputes Over Knee, Shoulder Implants With Conformis
MT
11/15Medacta Group SA announces the final settlement in the Conformis case
EQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
11/29/2022 11/30/2022 12/01/2022 12/02/2022 12/05/2022 Date
98.7(c) 101(c) 102.2(c) 100.4(c) 101(c) Last
18 509 7 469 3 383 5 777 5 147 Volume
-5.46% +2.33% +1.19% -1.76% +0.60% Change
More quotes
Estimated financial data (e)
Sales 2022 429 M 451 M 451 M
Net income 2022 56,2 M 59,0 M 59,0 M
Net Debt 2022 123 M 129 M 129 M
P/E ratio 2022 36,2x
Yield 2022 0,58%
Sales 2023 487 M 511 M 511 M
Net income 2023 69,9 M 73,4 M 73,4 M
Net Debt 2023 107 M 113 M 113 M
P/E ratio 2023 28,9x
Yield 2023 0,80%
Capitalization 2 041 M 2 145 M 2 145 M
EV / Sales 2022 5,05x
EV / Sales 2023 4,41x
Nbr of Employees 1 421
Free-Float 30,4%
More Financials
Company
Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee... 
More about the company
Ratings of Medacta Group SA
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about MEDACTA GROUP SA
11/15Global markets live: Amazon, Berkshire Hathaway, Infineon, Home Depo..
MS
11/15Medacta Settles Patent Disputes Over Knee, Shoulder Implants With Conformis
MT
11/15Medacta Group SA announces the final settlement in the Conformis case
EQ
11/06Medacta Says First US Hip Surgery Carried Out With Double Mobility Converter
MT
11/04Medacta Group Sa : Medacta Expands its Hip Offerings with New Cobalt-Free SensiTiN™ ..
EQ
10/12Medacta NextAR Spine wins the 2022 Spine Technology Award from Orthopedics This Week du..
EQ
10/05Medacta's MySpine Anchor Technology Used in First US Procedure
MT
10/05Medacta announces the first MySpine Anchor procedure completed in the US
EQ
09/21Medacta's MyKnee R Platform Becomes Part Of Revision Surgeries In US
MT
09/21Medacta announces first revision surgeries in the US using the unique-on-the-market and..
EQ
09/09Transcript : Medacta Group SA, H1 2022 Earnings Call, Sep 09, 2022
CI
09/09Swiss Orthopedic Group Medacta Lifts FY22 Outlook as H1 Revenue Grows; Profit Slows
MT
09/09Medacta : 2022 Half-Year Report
PU
09/09Medacta : 2022 Half-Year Presentation
PU
09/09Medacta Group SA reports strong revenue growth of 19.0% and adjusted EBITDA margin of 2..
EQ
More news
News in other languages on MEDACTA GROUP SA
11/29Aktien Schweiz Schluss: SMI klar im Minus - Vor allem Nestlé bela..
11/28Chine, le ras-le-bol sanitaire
11/28Avis d'analystes du jour : BNP Paribas, Vinci, AB Inbev, Hugo B..
11/15Bourse Zurich: les indices repartent à la hausse au lendemain d'un repli
11/15Borsa svizzera: chiude in rialzo, SMI +0,24%
More news
Analyst Recommendations on MEDACTA GROUP SA
More recommendations
ETFs positioned on MEDACTA GROUP SAETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
UBS ETF (CH) - MSCI Switzerland IMI Sociall...0.14%0.11%-NC
UBS ETF (CH) MSCI Switzerland IMI Socially ...0.13%-0.02%-NC
IShares Edge MSCI Multifactor Intl Small-Ca...0.13%0.49%World
UBS ETF - MSCI Switzerland IMI Socially Res...0.13%0.12%-NC
IShares MSCI Europe Small-Cap ETF - USD0.06%1.46%Europe
More ETFs positioned on MEDACTA GROUP SA
Chart MEDACTA GROUP SA
Duration : Period :
Medacta Group SA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDACTA GROUP SA
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 102,16 €
Average target price 107,65 €
Spread / Average Target 5,37%
EPS Revisions
Managers and Directors
Francesco Siccardi Chief Executive Officer
Corrado Farsetta Chief Financial Officer
Alberto Siccardi Non-Executive Chairman
Victor Waldemar Balli Lead Independent Non-Executive Director
Philippe A. Weber Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
MEDACTA GROUP SA-28.87%2 145
ABBOTT LABORATORIES-23.20%188 463
MEDTRONIC PLC-23.04%105 909
BECTON, DICKINSON AND COMPANY2.69%71 518
DEXCOM, INC.-12.01%45 621
HOYA CORPORATION-18.03%36 935